Compare · Nootropic peptide
Cerebrolysin vs Selank
Both are nootropic peptide compounds. Here's how they line up on the evidence — graded the same way.
| Cerebrolysin | Selank | |
|---|---|---|
| Evidence | Preliminary human | Preliminary human |
| Class | Nootropic peptide | Nootropic peptide |
| Summary | Cerebrolysin has more human trial data than most research peptides, yet its largest rigorous stroke trial was neutral and independent reviews find little benefit. | A Russian-developed anxiolytic peptide approved in Russia but unproven by Western standards; human trials are small, early, and single-country. |
| Full profile → | Full profile → |
Cerebrolysin
Cerebrolysin is one of the more genuinely studied compounds in the "nootropic peptide" category. Unlike most research peptides, it has a real prescription history abroad, multiple randomized controlled trials, and several Cochrane systematic reviews. That sounds promising until you look at what…
Selank
Selank is a synthetic peptide developed in Russia and marketed online as an anti-anxiety and "nootropic" compound. The human evidence is real but thin, almost entirely Russian, and small in scale.